Skip to Content


In the US, Anidulafungin (anidulafungin systemic) is a member of the drug class echinocandins and is used to treat Candidemia and Esophageal Candidiasis.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antifungal agent

Chemical Names

(4R,5R)-4,5-Dihydroxy-N²-[[4''-(pentyloxy)-p-terphenyl-4-yl]carbonyl]-L-ornityl-L-treonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4(p-hydroxyphenyl)-L-treonyl-L-treonyl-(3S,4S)-3-hydroxy-4-metyl-L-proline cyclic (6->1)-peptide (WHO)

Echinocandin B, 1-[(4R,5R)-4,5-dihydroxy-N²-[[4''-(pentyloxy)[1,1':4',1''-terphenyl]-4-yl]carbonyl]-L-ornitine]- (USAN)

Foreign Names

  • Anidulafunginum (Latin)
  • Anidulafungin (German)
  • Anidulafungine (French)
  • Anidulafungina (Spanish)

Generic Names

  • Anidulafungin (OS: USAN, BAN)
  • LY303366 (IS: Lilly)
  • LY-307853 (IS)
  • LY-329960 (IS)
  • LY-333006 (IS)
  • VEC (IS)
  • V-Echinocandin (IS)
  • VER-002 (IS)

Brand Names

  • Ecalta
    Haemato Pharm, Austria; Laboratorio Pfizer de Chile, Chile; Pfizer, Argentina; Pfizer, Austria; Pfizer, Belgium; Pfizer, Switzerland; Pfizer, Cyprus; Pfizer, Czech Republic; Pfizer, Denmark; Pfizer, Spain; Pfizer, Finland; Pfizer, France; Pfizer, United Kingdom; Pfizer, Greece; Pfizer, Croatia (Hrvatska); Pfizer, Hungary; Pfizer, Indonesia; Pfizer, Ireland; Pfizer, Lithuania; Pfizer, Norway; Pfizer, Peru; Pfizer, Poland; Pfizer, Romania; Pfizer, Sweden; Pfizer, Slovenia; Pfizer, Slovakia; Pfizer Italia, Italy; Pfizer Luxembourg, Bosnia & Herzegowina
    Pfizer, Germany
  • Eraxis
    Pfizer, Australia; Pfizer, Canada; Pfizer, Hong Kong; Pfizer, Malaysia; Pfizer, Philippines; Pfizer, Thailand; Pfizer, Turkey; Pfizer, Taiwan; Pharmacia, Israel; Roerig, United States


BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.